Heron Therapeutics Inc

2
1
NEW
NAS:HRTX (USA)   Ordinary Shares
$ 1.74 -0.06 (-3.33%) 04:00 PM EST
At Loss
Market Cap:
$ 263.90M
Enterprise V:
$ 384.37M
Volume:
1.20M
Avg Vol (2M):
1.78M
Trade In:
Volume:
1.20M
At Loss
Avg Vol (2M):
1.78M

Business Description

Heron Therapeutics Inc
NAICS : 325412 SIC : 2833
ISIN : US4277461020

Share Class Description:

HRTX: Ordinary Shares
Description
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Name Current Vs Industry Vs History
Cash-To-Debt 0.38
Equity-to-Asset -0.17
Debt-to-Equity -4.71
Debt-to-EBITDA -4.5
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -11.17
Distress
Grey
Safe
Beneish M-Score -3.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.86
9-Day RSI 45.35
14-Day RSI 44.84
6-1 Month Momentum % -14.22
12-1 Month Momentum % 215.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.38
Quick Ratio 1.85
Cash Ratio 0.84
Days Inventory 332.11
Days Sales Outstanding 181.83
Days Payable 28.98

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.1
Shareholder Yield % -8.15

Financials (Next Earnings Date:2024-11-14 Est.)

HRTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:HRTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Heron Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 136.361
EPS (TTM) ($) -0.3
Beta 1.96
Volatility % 136.64
14-Day RSI 44.84
14-Day ATR ($) 0.124925
20-Day SMA ($) 1.8565
12-1 Month Momentum % 215.87
52-Week Range ($) 0.5 - 3.93
Shares Outstanding (Mil) 151.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Heron Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Heron Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Heron Therapeutics Inc Frequently Asked Questions

What is Heron Therapeutics Inc(HRTX)'s stock price today?
The current price of HRTX is $1.74. The 52 week high of HRTX is $3.93 and 52 week low is $0.50.
When is next earnings date of Heron Therapeutics Inc(HRTX)?
The next earnings date of Heron Therapeutics Inc(HRTX) is 2024-11-14 Est..
Does Heron Therapeutics Inc(HRTX) pay dividends? If so, how much?
Heron Therapeutics Inc(HRTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1